Medpace Holdings Inc (MEDP)
NASDAQ · Healthcare · Diagnostics & Research
Medpace Holdings Inc is a Healthcare company with a market capitalization of $15.05B and a trailing P/E ratio of 33.2.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | April 22, 2026 | $4.28 | $3.96 | +8.1% |
| Q4 2025 | February 9, 2026 | $4.67 | $4.18 | +11.7% |
| Q3 2025 | October 22, 2025 | $3.86 | $3.57 | +8.1% |
| Q2 2025 | July 21, 2025 | $3.10 | $3.00 | +3.3% |
| Q1 2025 | April 21, 2025 | $3.67 | $3.07 | +19.5% |
| Q4 2024 | February 10, 2025 | $3.68 | $3.12 | +18.1% |
Other Diagnostics & Research Stocks
Frequently Asked Questions
What is Medpace Holdings Inc's market cap?
As of June 29, 2026, Medpace Holdings Inc (MEDP) has a market capitalization of $15.05B.
What is Medpace Holdings Inc's P/E ratio?
Medpace Holdings Inc trades at a trailing price-to-earnings (P/E) ratio of 33.2. Its forward P/E is 31.3.
Does Medpace Holdings Inc pay a dividend?
Medpace Holdings Inc does not currently pay a dividend.
What sector is MEDP in?
Medpace Holdings Inc is in the Healthcare sector, specifically the Diagnostics & Research industry.
What was Medpace Holdings Inc's revenue?
In its latest reported fiscal year (ending December 31, 2025), Medpace Holdings Inc reported revenue of $2.53B and net income of $451.12M.
Ask your own questions about MEDP
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.